Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2. Morse MA, Hobeika A, Osada T, Niedzwiecki D, Marcom PK, Blackwell KL, Anders C, Devi GR, Lyerly HK, Clay TM J Transl Med 2007, 5:42 [Full text] [PubMed] [Related articles]
|
No citations for this article were found in PubMed Central.
|